chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Every time I got a flu shot, I'd get the flu; Initial information received on 29-Dec-2021 regarding an unsolicited valid Social Media non-serious case received from via a patient.  This case involves Adult and unknown gender patient who experienced every time i got a flu shot, i'd get the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer formulation, strength and lot number not reported via unknown route in unknown administration site for immunisation.  On an unknown date the patient developed a non-serious event "every time i got a flu shot, i'd get the flu" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Patient reported that "Every time I got a flu shot, I'd get the flu. The last time I got the H1N1 shot, I ended up in the hospital. Since I stopped getting the flu shots, guess what? I HAVEN'T HAD THE FLU! In almost 15 years. Crazy how that works".  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Every time I got a flu shot, I'd get the flu).  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event every time i got a flu shot, i'd get the flu.
Since the second dose, I now have a strange daily occurrence of a dry cough and dry heaves.  Sometimes vomiting.
I started having Covid-19 symptoms on 11/20/202, first thing I noticed is I was weak, I was sore, and my ears ached. I saw my doctor on 11/22/2021 and they tested me for Covid-19. They prescribed azithromycin because he did not know at the time if it was bronchitis. About an hour later they called me and they said my test was positive and to continue to take that medication. I could not smell or taste for a long time, for like a month.
102.4 fever, sore red arm, fever, chills, purple streaks on right arem
I felt dizzy and got hot and my legs started shaking. I had a seizure for about a minute and then collapsed to the floor and fainted for a few seconds. I hit my knee mildly but not my head.
Approximately 9 hours after vaccines, the patient developed fretfulness, rigid arms and severe crying for 10 minutes.
problems sleeping; Body ache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (problems sleeping), CHILLS (Chills) and MYALGIA (Body ache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced CHILLS (Chills). On an unknown date, the patient experienced SLEEP DISORDER (problems sleeping) and MYALGIA (Body ache). At the time of the report, SLEEP DISORDER (problems sleeping), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Bumps on hands, arms. Redness on hands, arms, neck, face. Itching.
Fainted, came to and left with mother and sibling about 25min with 0 complaints
No reactions occurred. Vaccine administered on 5/17/2022, however due to it being kept in the fridge, it should have expired on 4/8/22, therefore patient received expired vaccine.
take the shingles vaccine and he got shingles/ suspected vaccination failure; he got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a elderly male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The patient was reporter's uncle. The age at vaccination was not reported but the patient was in his 80's. The patient never had Shingles and then taken the Shingles vaccine and he got shingles from it. The reporter stated that we better be careful what we allow them to inject us with. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Booster dose side effects; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (Booster dose side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Booster dose side effects). At the time of the report, VACCINATION COMPLICATION (Booster dose side effects) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant and Treatment medication were reported.
Pt exp polyuria, inc thirst, blurred vision from 1AUG91 to 9AUG91 exp a twenty pound weight loss; dx of diabetes on 9AUG91;
date above is approximate. received Lymerix, had 50% energy/health after,; took many years of treatments to get to 85 % energy/health approximate date above. I have all medical records from time of vaccine given before/after
Sore right arm the first day of injection.  Very painful/achy muscles and joints,  headache, nausea + fever all night through mid-morning the next day.  Took 2 ibuprofen upon waking -- fever gone.   General muscle/joint achiness subsided by late morning, though soreness in right persisted one more day.
Psoriasis which I have all over my body started clearing up/also have psoriatic arthritis It seems to have eased it some; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Aug2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, psoriatic arthritis, and psoriasis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Aug2021, immediately after the first dose of the vaccine, psoriasis which the patient had all over the body started clearing up. The vaccine had worked better than any medicine that the patient had ever tried and the patient had psoriasis since she was 18-years-old. The patient also had psoriatic arthritis which seemed to have eased it some. The patient received the second dose on 12Sep2021 and would see the affect as time goes on. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event psoriasis which the patient had all over body started clearing up/also had psoriatic arthritis which seemed to have eased it some was unknown. The patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration on 12Sep2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
neurological side effects; cold and flu symptoms; cold and flu symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an occupational therapist and describes the occurrence of NERVOUS SYSTEM DISORDER (neurological side effects), NASOPHARYNGITIS (cold and flu symptoms) and INFLUENZA (cold and flu symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVOUS SYSTEM DISORDER (neurological side effects), NASOPHARYNGITIS (cold and flu symptoms) and INFLUENZA (cold and flu symptoms). At the time of the report, NERVOUS SYSTEM DISORDER (neurological side effects), NASOPHARYNGITIS (cold and flu symptoms) and INFLUENZA (cold and flu symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter. Batch Number: Unknown manufacturer(s). Occupational Therapist reporting that a lot of people are reporting neurological side effects online lasting up to 6 months and some are reporting cold and flu symptoms.
Concerns about dosage. Child given .5cc of FLULAVAL Adult vaccine in the office. Concerned about reactions for the patient. Concerned about adjevent and effect on children. Call to local health department. They advised parents be notified of possible elevated temp and swelling and redness at injection site. Call made to Glaxo requesting info - message left to call the office back.
Feeling of Faintness, yawning, brain fog, loss of strength. Swelling of upper body. Breast tenderness, irregular menstrual bleeding, increased allergies and Chemical Sensitivities overall, allergy to Estradiol patch.  Fatigue, itching.  Tightness of chest, bronchial spasms, shortness of breath
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 17Dec2021 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 31 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "ADHD" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Oct2023) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 21Oct2023 to 26Oct2023. Clinical course: The patient had no known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300352179 Same reporter/patient, different drug, different AE.;
Expired vaccine given to patient; vaccine expired 1/30/23. HAVRIX second dose of active vaccine given
pt fell & hit the back of head approx 3 to 5 min p/vax;pt was awake, pale, & crying p/falling;pt was taken to ER for exam
red, warm, hard, wheel like rash with vesicular lesions , worsened after first onset for 24 hours then started to improved. treated with supportive care and close follow up
severely dehydrated; cramping lower abdomen; flu like symptoms; intense vomiting; headache; fever; nausea; disoriented; cramping; A spontaneous report was received from a consumer who was also an 83-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced severe dehydration/Dehydration, cramping in lower abdomen/ abdominal pain lower, fever/pyrexia, nausea, headache, disorientation, flu like symptoms/ Influenza like illness, intense vomiting/ vomiting and cramping/ muscle spasms.  Patient's medical history was not provided, and concomitant medicines were not reported.   On 25 Jan 2021, the same day as the onset of symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection.  Patient reported that she initially had an "extreme reaction" with severe, flu-like symptoms, headache, fever, disorientation, nausea and dehydration.  She reported that she had a fever within three hours of receiving the vaccination. She stated that she suffered extreme vomiting for three and a half weeks along with ongoing headache, fever and cramping.  On an unknown date, she was in the hospital, or ER, where she received medication for nausea and intravenous medication for dehydration (unknown if hospitalized}.  She reported eight hours of pain/cramping in her lower abdomen, and again, stated that she was severely dehydrated.  (The duration of hospitalization or ER visit was not reported).  At the time of reporting, she said that her symptoms were ongoing, however, much less severe.   Treatment included was nausea medication (patient did not remember the drug's name), intravenous (IV) medication for dehydration, IV antibiotics and dicycloverine.   Action taken with mRNA-1273 was not reported.  The outcomes of the events,  dehydration, cramping in lower abdomen, fever, nausea, headache, disorientation, flu like symptoms, intense vomiting and cramping, were considered recovering/resolving.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
In the afternoon, about 24 hrs post-vaccination, we noticed a rash across the front of her thigh, underneath the injection site. It was irregular/blotchy red horizontal stripes, with normal-looking skin stripes in between the rash part. The injection site itself was a red bump, somewhat smaller than dime-size. Several hours later, the same striped rash had spread another inch or so down her thigh, almost to her knee. The rash did not seem to itch or hurt her.
In morning patient started to feel better and next day did not feel good; Muscles are feeling weak; hard to concentrate; 3 weeks now and symptoms are not going away; very tired; patient's body started shaking; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TREMOR (patient's body started shaking), FEELING ABNORMAL (In morning patient started to feel better and next day did not feel good), MUSCULAR WEAKNESS (Muscles are feeling weak), DISTURBANCE IN ATTENTION (hard to concentrate) and SYMPTOM RECURRENCE (3 weeks now and symptoms are not going away) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced TREMOR (patient's body started shaking), MUSCULAR WEAKNESS (Muscles are feeling weak), DISTURBANCE IN ATTENTION (hard to concentrate), SYMPTOM RECURRENCE (3 weeks now and symptoms are not going away) and FATIGUE (very tired). On 17-Apr-2021, the patient experienced FEELING ABNORMAL (In morning patient started to feel better and next day did not feel good). At the time of the report, TREMOR (patient's body started shaking), FEELING ABNORMAL (In morning patient started to feel better and next day did not feel good), MUSCULAR WEAKNESS (Muscles are feeling weak), DISTURBANCE IN ATTENTION (hard to concentrate), SYMPTOM RECURRENCE (3 weeks now and symptoms are not going away) and FATIGUE (very tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, COVID-19: unknown (Inconclusive) unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
General malaise; Fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of general malaise in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced general malaise (Verbatim: General malaise) and fever (Verbatim: Fever). The outcome of the general malaise and fever were unknown.   It was unknown if the reporter considered the general malaise and fever to be related to Shingles vaccine.     It was unknown if the company considered the general malaise and fever to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient received 2 doses of Shingles vaccine and experienced general malaise and fever a day after administered it on. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR067448:Same patient
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 29-DEC-2014, the patient was vaccinated with improperly stored VAQTA (strength: 25/0 (unit  unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Rather sudden onset of severe headache, severe shaking chills, absence of fever, severe nausea, persistent vomiting. lasting about 4 hours, relieved with zofran.  Tired and muscle aches following day with persistent headache 48 hours
Breakthrough case admission after 2 vaccines Moderna 10/29/21 lot# 939904;  Moderna 11/22/22 Lot# 059F22A
This report was received from a physician assistant via a vendor referring to a 12 year old male patient who was enrolled in a market research. The patient was a healthy kid without any concurrent condition or concomitant therapy. In March 2016 the patient was vaccinated with the first dose of GARDASIL 9 (lot# and expiration date were not reported) intramuscularly. On an unknown date in 2016 the patient went out from exam room and while he was sitting waiting, he fainted/ felt dizzy. There was no lab test was done. The patient recovered from the event with sequelae on the same day (it was also reported as recovering). The reporter stated that the patient tolerated the vaccine and it was unsure that if the issue was that he was nervous about getting blood drawn. The reporter considered the event to be not related to GARDASIL 9. Additional information has been requested.
19 month old female patient administered expired dose of ActHib, no AE; Initial information received on 01-Dec-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 19 month old female patient who was vaccinated with an expired dose of HIB (PRP/T) VACCINE [ACT-HIB] (expired product administered).  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A VACCINE) for Immunisation.  On 01-Dec-2020, the patient received a 0.5 ml dose of suspect HIB (PRP/T) VACCINE (lot UJ135ABA and expiry date: 26-Nov-2020) via an unknown route in the left thigh for prophylactic vaccination.  It was a case of actual medication error due to expired vaccine used (latency on same day).  Reporter relationship: HCP (health care professional), product used: used and still using product: no  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Mild arm soreness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Mild arm soreness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (Mild arm soreness). At the time of the report, VACCINATION SITE PAIN (Mild arm soreness) had not resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
administration of improperly stored vaccines; This spontaneous report was received from a medical assistant, referring to a 2-years-old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions and previous drug reactions or allergies was not provided.   On 27-AUG-2020, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (dose was unknown by the reporter; strength, vaccination scheme frequency, route of administration, and anatomical location were not reported; lot number T002848, which have been verified to be valid, expiration date reported and validated as 23-JAN-2022) as prophylaxis (product storage error). The use of a sterile diluent was reported (dose, lot number and expiration date were unknown by the reporter).  The administered dose of the vaccine experienced a temperature excursion of 6 degrees Fahrenheit (F) to 14 degrees F (10.56 degrees F) for 50 minutes, as recorded by a data logger. The previous temperature excursion reported was of 6 degrees F to 14 degrees F (8.47 degrees F) for 30 minutes.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2009USA000747: US-009507513-2009USA000777: US-009507513-2009USA000676: US-009507513-2009USA000699: